Molecular bases of the main CYP2D6 gene genetic polymorphisms, ethnic differences and pharmacological consequences

Authors

  • Paola M. Casas Lab. de Biología Molecular, de la Facultad de Farmacia y Bioquímica de la Universidad Nacional Mayor de San Marcos, Lima, Perú.
  • Amparo l. Zavaleta Lab. de Biología Molecular, de la Facultad de Farmacia y Bioquímica de la Universidad Nacional Mayor de San Marcos, Lima, Perú.
  • Víctor lzaguirre Lab. de Biología Molecular, de la Facultad de Farmacia y Bioquímica de la Universidad Nacional Mayor de San Marcos, Lima, Perú.
  • Marisol López Departamento de Sistemas Biológicos. Universidad Autónoma Metropolitana. Unidad Xochimilco. México, D.F. México.

DOI:

https://doi.org/10.15381/ci.v10i2.4968

Keywords:

Genetic polymorphism, CYP2D6, pharmacogenetics, genotyping

Abstract

The CYP2D6 gene metabolizes approximately 25 % of drugs of clinical use and exhibits a marked genetic variation, thus according to the allelic variants carried by each individual three types of metabolism can be observed: poor (PM), extensive (EM) or ultrarapid (UM). There is also interethnic variation in the frequencies of PM, EM and UM individuals. Knowledge of the individual CYP2D6 metabolic status may be clinically and economically important and could provide the basis for a rational approach to drug prescription.

Downloads

Published

2007-12-31

Issue

Section

Articulos de Revisión

How to Cite

1.
Casas PM, Zavaleta A l., lzaguirre V, López M. Molecular bases of the main CYP2D6 gene genetic polymorphisms, ethnic differences and pharmacological consequences. Ciencia e investigación [Internet]. 2007 Dec. 31 [cited 2024 Jul. 17];10(2):89-101. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/farma/article/view/4968